301015 百洋医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)19.62026.26727.42522.72223.236
总资产报酬率 ROA (%)6.48010.22312.44010.5189.801
投入资产回报率 ROIC (%)8.39913.68615.94812.90112.402

边际利润分析
销售毛利率 (%)37.38335.50333.29527.76125.127
营业利润率 (%)12.55512.07912.6418.9797.963
息税前利润/营业总收入 (%)13.74912.82013.2469.5478.888
净利润/营业总收入 (%)9.9639.4769.3356.5235.885

收益指标分析
经营活动净收益/利润总额(%)95.31595.70697.201101.35497.099
价值变动净收益/利润总额(%)9.7746.3034.398-1.3271.729
营业外收支净额/利润总额(%)-1.609-1.149-1.519-0.8540.696

偿债能力分析
流动比率 (X)1.5521.5692.1401.6351.704
速动比率 (X)1.3161.2841.7801.3861.444
资产负债率 (%)63.59463.37951.39154.68852.767
带息债务/全部投入资本 (%)56.79952.59637.05940.60441.420
股东权益/带息债务 (%)72.26885.200162.285137.491139.615
股东权益/负债合计 (%)51.40252.68387.66083.67188.824
利息保障倍数 (X)9.87114.59416.66814.81710.218

营运能力分析
应收账款周转天数 (天)82.95390.46191.82293.13487.171
存货周转天数 (天)66.62261.69749.41242.27042.077